22 research outputs found
MTRX1011A, a humanized anti-CD4 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a Phase I randomized, double-blind, placebo-controlled study incorporating pharmacodynamic biomarker assessments
Get PDFIn vitro internalization, intracellular transport, and clearance of an anti-CD11a antibody (Raptiva) by human T-cells." J Pharmacol Exp Ther 310(3
No full textABSTRACT Efalizumab (Raptiva) is a humanized CD11a-specific monoclonal antibody that was recently approved for the treatment of moderate to severe psoriasis. In psoriasis patients, the rate of efalizumab clearance from serum is related to T-cell surface expression of CD11a, suggesting a receptor-mediated clearance model for efalizuma
Establishing a Classroom Environment That Promotes Interaction and Improved Student Behavior
No full textImpact of Adaptive Materials on Teachers and their Students with Visual Impairments in Secondary Science and Mathematics Classes
No full text
Effective Charter and Traditional School Characteristics: Aligning Findings for Informed Policy Making
No full text
Tactile Earth and Space Science Materials for Students with Visual Impairments: Contours, Craters, Asteroids, and Features of Mars
No full text
